New Jersey 2026-2027 Regular Session

New Jersey Assembly Bill AJR148

Introduced
2/19/26  

Caption

Designates October of each year as "Menopause Awareness Month" October 11 of each year as "Perimenopause Day," and October 18 of each year as "Postmenopause Day" in New Jersey.

Impact

The resolution targets the essential yet often taboo subject of menopause, aiming to break the silence surrounding its effects on women's lives. With many women experiencing symptoms such as hot flashes, mood swings, and disruptions to daily life, the resolution seeks to encourage discussion and education amongst families, communities, and healthcare providers. Through these designations, New Jersey aligns itself with international recognition by organizations like the International Menopause Society and the World Health Organization, improving visibility and support for women's health issues related to menopause.

Summary

AJR148 is a joint resolution introduced in New Jersey's legislature that designates October as 'Menopause Awareness Month' and establishes specific days to recognize 'Perimenopause Day' on October 11 and 'Postmenopause Day' on October 18 each year. This designation aims to raise awareness of menopause, which is a natural biological process marking the cessation of menstrual cycles in women, typically occurring around the age of 51 but can start as early as one’s 40s. The resolution emphasizes the importance of recognizing the various stages of menopause, including perimenopause and postmenopause, and their associated symptoms.

Conclusion

In summary, AJR148 represents a critical step towards fostering understanding and support for women navigating menopause. By designating specific months and days to focus on this natural process, it compels both public and private sectors to engage in conversation and education aimed at reducing stigma, ultimately leading to better health outcomes for women. The resolution calls for the governor’s proclamation which could catalyze public initiatives and programs dedicated to women’s health.

Contention

While AJR148 promotes awareness of menopause, discussions around its efficacy and the potential need for additional resources to support women experiencing these changes may arise. Concerns could be raised about whether this awareness correlates with adequate healthcare access and information dissemination in New Jersey. The acknowledgment of menopause awareness could lead to demands for improved medical support and health education tailored for women in transition periods, suggesting a multifaceted approach is necessary for addressing the complexities of menopause.

Companion Bills

NJ AJR123

Carry Over Designates September of each year as "Menopause Awareness Month" in New Jersey.

NJ SJR85

Carry Over Designates October of each year as "Menopause Awareness Month" October 11 of each year as "Perimenopause Day," and October 18 of each year as "Postmenopause Day" in New Jersey.

NJ SJR62

Same As Designates October of each year as "Menopause Awareness Month," October 11 of each year as "Perimenopause Day," and October 18 of each year as "Postmenopause Day" in New Jersey.

Similar Bills

AZ HB2734

Perimenopause; menopause; education

NJ SJR62

Designates October of each year as "Menopause Awareness Month," October 11 of each year as "Perimenopause Day," and October 18 of each year as "Postmenopause Day" in New Jersey.

NJ S2825

Establishes interagency council on menopause in DOH and requires certain lincensed health care professionals to distribute menopause informational pamphlets under certain circumstances.

MA H5303

Expanding access to perimenopause and menopause care

OH HB767

Enact Menopause, Perimenopause, and Hormone Therapy Coverage Act

AZ HB2929

perimenopause; menopause; task force

PA HR287

Directing the Joint State Government Commission to conduct a study and issue a report on workplace policies related to perimenopause and menopause offered by public and private employers.

NJ S722

Establishes "New Jersey Menopause Coverage Act"; requires health insurance coverage of medically necessary perimenopause and menopause treatments.